Clincosm LogoSign in Get a demo

Chronic Obstructive Pulmonary Disease

Showing NaN - NaN of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD Trial in Worldwide (Benralizumab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Benralizumab
  • Placebo
  • Montgomery, Alabama
  • +400 more
Jan 11, 2023

Pulmonary Hypertension, COPD Trial in Israel, United States (Inhaled treprostinil solution)

Terminated
  • Pulmonary Hypertension
  • Chronic Obstructive Pulmonary Disease
  • Inhaled treprostinil solution
  • Birmingham, Alabama
  • +29 more
Jan 5, 2023

Pulmonary Hypertension, COPD Trial in Worldwide (Inhaled treprostinil solution, Placebo solution)

Terminated
  • Pulmonary Hypertension
  • Chronic Obstructive Pulmonary Disease
  • Inhaled treprostinil solution
  • Placebo solution
  • Birmingham, Alabama
  • +75 more
Jan 5, 2023

COPD Trial in Worldwide (Itepekimab SAR440340, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Itepekimab SAR440340
  • Placebo
  • Palm Springs, California
  • +231 more
Dec 19, 2022

COPD Trial in Worldwide (Ensifentrine, Placebo)

Active, not recruiting
  • Chronic Obstructive Pulmonary Disease
  • Peoria, Arizona
  • +133 more
Dec 5, 2022

COPD Trial in Worldwide (Ensifentrine, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Alabaster, Alabama
  • +140 more
Nov 30, 2022

Observational Study of Obstructive Lung Disease (NOVELTY)

Active, not recruiting
  • Asthma
  • +2 more
  • Blood draw
  • +3 more
  • Loma Linda, California
  • +302 more
Nov 22, 2022

COPD Trial in Worldwide (Astegolimab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Andalusia, Alabama
  • +170 more
Aug 4, 2022

Pulmonary Hypertension, COPD Trial in United States (Inhaled NO delivered via INOpulse DS-C Device, Placebo delivered via

Completed
  • Pulmonary Hypertension
  • Chronic Obstructive Pulmonary Disease
  • Inhaled NO delivered via INOpulse DS-C Device
  • Placebo delivered via INOpulse DS-C Device
  • Jasper, Alabama
  • +42 more
Jul 13, 2022

COPD Trial in Worldwide (Itepekimab SAR440340, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Itepekimab SAR440340
  • Placebo
  • Birmingham, Alabama
  • +158 more
Jul 13, 2022

COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Dupilumab SAR231893
  • +4 more
  • Cullman, Alabama
  • +334 more
Jun 14, 2022

COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)

Active, not recruiting
  • Chronic Obstructive Pulmonary Disease
  • Dupilumab SAR231893
  • +4 more
  • Andalusia, Alabama
  • +286 more
May 11, 2022

COPD Trial in United States (Revefenacin, Tiotropium, Revefenacin Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Jasper, Alabama
  • +38 more
May 4, 2022

COPD, COPD Trial in United States (CHF 5259, Placebo, Tiotropium Bromide 18 µg Inhalation Capsule)

Completed
Has Results
  • COPD
  • Chronic Obstructive Pulmonary Disease
  • CHF 5259
  • +2 more
  • Birmingham, Alabama
  • +111 more
May 20, 2021

COPD Trial in United States (Placebo, Test Product (tiotropium bromide inhalation powder), Reference Product (Spiriva®))

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Placebo
  • +2 more
  • Andalusia, Alabama
  • +33 more
Mar 10, 2021

COPD Trial in Clearwater (PT010)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Clearwater, Florida
    Research Site
Jan 12, 2021

COPD Trial in Worldwide (GFF MDI (PT003), FF MDI (PT005), GP MDI (PT001))

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • GFF MDI (PT003)
  • +3 more
  • Andalusia, Alabama
  • +166 more
Jan 28, 2019

COPD, COPD, Moderate to Very Severe COPD Trial in Canada, United States (Aclidinium Bromide, Placebo)

Completed
Has Results
  • COPD
  • +2 more
  • Aclidinium Bromide
  • Placebo
  • Birmingham, Alabama
  • +467 more
Nov 8, 2018

COPD Trial in Worldwide (Aclidinium bromide 400 µg/Formoterol Fumarate 12 µg (AB/FF 400/12 µg), Aclidinium bromide 400 µg (AB

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium bromide 400 μg/Formoterol Fumarate 12 μg (AB/FF 400/12 μg)
  • +5 more
  • Gulf Shores, Alabama
  • +162 more
Nov 7, 2018

COPD Trial in United States (BFF MDI 320/9.6 µg, BFF MDI 160/9.6 µg, BFF MDI 80/9.6 µg)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • BFF MDI 320/9.6 μg
  • +4 more
  • Rolling Hills Estates, California
  • +16 more
May 23, 2018

COPD Trial in United States (QVA149, Umeclidinium/vilanterol, Placebo (umeclidinium/vilanterol ))

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Anaheim, California
  • +52 more
Mar 2, 2018

COPD Trial in United States (MP-376, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Haleyville, Alabama
  • +38 more
Jan 17, 2018

COPD Trial in United States (PT001 MDI, Tiotropium Bromide, PT001 Placebo MDI)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • PT001 MDI
  • +2 more
  • Fullerton, California
  • +9 more
Oct 10, 2017

COPD Trial in United States (Aclidinium Bromide/Formoterol Fumarate, Formoterol Fumarate)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Aclidinium Bromide/Formoterol Fumarate
  • Formoterol Fumarate
  • Birmingham, Alabama
  • +136 more
Apr 3, 2017

COPD Trial in United States (PT003, PT001, PT005)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Rancho Mirage, California
  • +12 more
Apr 26, 2017